Autologous Activated Platelet Rich Plasma Holds Potential in COVID-19 Treatment

Research studies from Indonesia are grabbing the attention of stakeholders in the platelet rich plasma market. Due to the increasing number of COVID-19 cases in Indonesia, autologous activated platelet-rich plasma (aaPRP) has been gaining recognition for potentials in suppressing cytokine release syndrome (CRS) in patients. Since cytokine storm has been a typical symptom among coronavirus patients in Indonesia, intravenous autologous activated platelet-rich plasma holds promising potentials to reduce death rates.

Postponement and rescheduling of medical treatments have affected revenue flow in the platelet rich plasma market during the ongoing pandemic. Nevertheless, companies are implementing comprehensive vendor reviews to ensure robust medical supplies at healthcare facilities. They are reviewing processes for monitoring expiration dates and replace old supplies with new ones.

platelet rich plasma market infographic

Request a sample to get extensive insights into the Platelet Rich Plasma Market

Need for Official FDA Approval in End-use Cases Hampers Market Growth

The platelet rich plasma market is expected to reach the valuation of US$ 815.3 Mn by 2031. Although the equipment used to produce PRP and the injections have been cleared by the FDA (Food and Drug Administration), this procedure is considered investigational and has not been officially approved by the FDA for many uses. Nevertheless, PRP is a low-risk procedure and linked with minor side effects.

Outside of the orthopedic treatment, PRP is being used for the treatment of hair loss, for skin rejuvenation, and post-surgical healing. Healthcare companies are establishing stable revenue streams with the help of PRP injections meant for tendon, muscle, and join injuries.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Dramatic Skin Improvement with Cosmetic PRP Creating Revenue Opportunities

The platelet rich plasma market is slated to clock a robust CAGR of 11.2% during the forecast period. The American Society of Plastic Surgeons has been witnessing a significant increase in the use of cosmetic PRP in the past few years. This is evident, as treatments using PRP show great promise for harnessing the body’s own natural tissue repair processes to help patients achieve improved form and function.

Platelet rich plasma is being prepared by manufacturers in the platelet rich plasma market with the help of various methods such as centrifugation, which involves spinning a small sample of the patient’s blood into separate components, followed by other steps. The growing popularity of vampire facial consisting of non-surgical microneedling followed by topical application of PRP is creating revenue opportunities for market stakeholders.

PRP Improves Patient Quality of Life with Prevention of Orthopedic Surgery

Since PRP mimics the body’s natural healing process, companies in the platelet rich plasma market are tapping incremental opportunities in orthopedics. Increased levels of platelets lead to increased growth factors, which have the potential to improve signaling and recruitment of cells to promote quicker & efficient healing in complex orthopedic conditions in patients.

AOA Orthopedic Specialists has been gaining recognition for increasing the availability of PRP in order to either delay or prevent an orthopedic surgery or to use in conjunction with the surgery.

platelet rich plasma market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Platelet Rich Plasma Market

Analysts’ Viewpoint

As pharmaceutical and life sciences companies make changes to supply chains, stakeholders in the platelet rich plasma market are revisiting key assumptions in financial projections, owing to potential supply chain disruptions. PRP is gaining prominence in plastic surgery. However, for cosmetic procedures, the treatment can be potentially time consuming and may require multiple session, leading to high costs. Hence, stakeholders should increase awareness about the advantages of cosmetic PRP that shows dramatic improvements in skin contour. As such, PRP is being deployed for orthopedic conditions such as knee arthritis and promote healing after an orthopedic surgery. Companies in the platelet rich plasma market are enhancing their production capabilities to produce PRP for treatment of chronic tendon injuries, acute ligament injuries and fractures amongst others.

Platelet Rich Plasma Market: Overview

  • This report analyzes the current scenario and future prospects of the global platelet rich plasma market. Increase in awareness about platelet rich plasma therapies, rise in prevalence of various orthopedic diseases, and surge in demand for effective hair-loss treatment are the key factors projected to propel the global platelet rich plasma market during the forecast period.
  • Advantages and applications of PRP therapy over conventional wound healing and disease treatments, such as surgery and medicines, have resulted in higher demand for PRP products globally
  • The report includes an elaborate executive summary, which provides a snapshot of various segments of the global platelet rich plasma market. It also provides information and data analysis of the platelet rich plasma market based on type, origin, application, and region
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the global platelet rich plasma market
  • The report includes company profiles, which provide information about their business, product portfolios, and competitive landscape in the global platelet rich plasma market
  • The report on the platelet rich plasma market offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analysis of market share/position of key players operating in the global platelet rich plasma market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global platelet rich plasma market.

Platelet Rich Plasma Market: Key Segments

  • In terms of sample type, the global platelet rich plasma market has been classified pure PRP, leukocyte-rich PRP, and pure PRF. The pure PRP segment is projected to account for major share of the global platelet rich plasma market in the near future. The segment’s dominance can be ascribed to technological advancements of PRP devices leading to the use of pure PRP in various cases and rich platelet content are anticipated to boost the growth of the segment in the next few years. Technological advancements such as smart home diagnostic kits has also boosted the growth of the global market.
  • Based on origin, the global platelet rich plasma market has been categorized into autologous, allogenic, and homologus. The autologous segment dominated the global platelet rich plasma market in 2020. Autologous PRP is a safe, simple, and cost-efficient approach and has positive effect on cell proliferation, migration, and angiogenesis. Autologous PRP is quite beneficial in the treatment of chronic non-healing ulcers. This is expected to drive the demand for autologous PRP, especially in developed countries across the globe.
  • In terms of application, the global platelet rich plasma market has been segregated into orthopedic surgery, cosmetic surgery, general surgery, neurosurgery, and others. The orthopedic surgery is likely to account for major share of the global platelet rich plasma market during the forecast period. Rise in the number of orthopedic surgeries is projected to drive the segment during of the forecast period.
  • CAGR of respective segments has also been provided from 2021 to 2031, considering 2020 as the base year

Platelet Rich Plasma Market: Regional Outlook

  • In terms of region, the global platelet rich plasma market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, Switzerland, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
  • The platelet rich plasma market report provides size and forecast for each region and country/sub-region from 2017 to 2031. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The platelet rich plasma market study also covers the competitive scenario across the globe.

Companies Covered in Platelet Rich Plasma Market Report

  • Key players operating in the global platelet rich plasma market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the platelet rich plasma market report are
    • SelfDiagnostics
    • F. Hoffmann-La Roche Ltd.
    • Trinity Biotech plc
    • Bionime Corporation
    • ARKRAY, Inc.
    • ACON Laboratories, Inc.
    • Assure Tech. (Hangzhou) Co., Ltd.
    • Abbott
    • Becton
    • Dickinson and Company
    • Quidel Corporation

Platelet Rich Plasma Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 275.1 Mn

Market Forecast Value in 2031

US$ 893.3 Mn

Growth Rate (CAGR)

11.2%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porters Five Forces analysis, supply chain analysis, parent industry overview, etc.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, key financials, etc.

Format

Electronic (PDF) + Excel

Market Segmentation

  • Type
    • Pure-PRP
    • Leukocyte-rich PRP
    • Pure-PRF
  • Origin
    • Autologous
    • Allogeneic
    • Homologous
  • Application
    • Orthopedic Surgery
    • Cosmetic Surgery
    • General Surgery
    • Neurosurgery
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • South America

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Japan
  • China
  • India
  • South Korea
  • ASEAN
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Zimmer Biomet Holdings, Inc.
  • AdiStem Ltd.
  • ISTO Biologics
  • ThermoGenesis Holdings, Inc.
  • Stryker Corporation
  • Exactech, Inc.
  • EmCyte Corporation
  • Regen Lab
  • Arthrex, Inc.
  • TERUMO BCT, INC. (Terumo Corporation)
  • DePuy Synthes Companies (Johnson & Johnson)
  • APEX Biologix, LLC

Customization Scope

Available upon request

Pricing

Available upon request

Platelet Rich Plasma Market – Scope of Report

TMR’s report on the global platelet rich plasma market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global platelet rich plasma market for the period of 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global platelet rich plasma market during the forecast period.

The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global platelet rich plasma market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global platelet rich plasma market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global platelet rich plasma market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global platelet rich plasma market.

The report delves into the competitive landscape of the global platelet rich plasma market. Key players operating in the global platelet rich plasma market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global platelet rich plasma market that have been profiled in this report.

Key Questions Answered in Platelet Rich Plasma Market Report

  • What is the revenue forecast for the global platelet rich plasma market in terms of revenue for the period 2021–2031?
  • How would various dynamics such as drivers, restraints, opportunities, and trends affect the market?
  • What is the market size and estimation for the platelet rich plasma market across regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa?
  • Which regional market is poised to expand at a significant CAGR during the forecast period?
  • Which type segment is projected to generate considerable revenue in 2031 and which application segment will register the fastest CAGR during the forecast period?

Research Methodology

TMR has used a unique methodology to conduct comprehensive research on the growth of the global platelet rich plasma market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary researches, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global platelet rich plasma market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the platelet rich plasma market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the platelet rich plasma market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global platelet rich plasma market with accuracy. The study also uses the top-down approach to assess the revenue of each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global platelet rich plasma market more reliably and accurately.

Platelet Rich Plasma Market – Segmentation

Type
  • Pure-PRP
  • Leukocyte-rich PRP
  • Pure-PRF
Origin
  • Autologous
  • Allogeneic
  • Homologous
Application
  • Orthopedic Surgery
  • Cosmetic Surgery
  • General Surgery
  • Neurosurgery
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Platelet Rich Plasma Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Platelet Rich Plasma Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Regulatory Scenario by Region/globally

    5.2. Pricing Analysis

    5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Platelet Rich Plasma Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Type, 2017–2031

        6.3.1. Pure-PRP

        6.3.2. Leukocyte-rich PRP

        6.3.3. Pure-PRF

    6.4. Market Attractiveness Analysis, by Type

7. Global Platelet Rich Plasma Market Analysis and Forecast, by Origin

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Origin, 2017–2031

        7.3.1. Autologous

        7.3.2. Allogeneic

        7.3.3. Homologous

    7.4. Market Attractiveness Analysis, by Origin

8. Global Platelet Rich Plasma Market Analysis and Forecast, by Application

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Application, 2017–2031

        8.3.1. Orthopedic Surgery

        8.3.2. Cosmetic Surgery

        8.3.3. General Surgery

        8.3.4. Neurosurgery

        8.3.5. Others

    8.4. Market Attractiveness Analysis, by Application

9. Global Platelet Rich Plasma Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast By Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Country/Region

10. North America Global Platelet Rich Plasma Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Type, 2017–2031

        10.2.1. Pure-PRP

        10.2.2. Leukocyte-rich PRP

        10.2.3. Pure-PRF

    10.3. Market Value Forecast, by Origin, 2017–2031

        10.3.1. Autologous

        10.3.2. Allogeneic

        10.3.3. Homologous

    10.4. Market Value Forecast, by Application, 2017–2031

        10.4.1. Orthopedic Surgery

        10.4.2. Cosmetic Surgery

        10.4.3. General Surgery

        10.4.4. Neurosurgery

        10.4.5. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Type

        10.6.2. By Origin

        10.6.3. By Application

        10.6.4. By Country

11. Europe Global Platelet Rich Plasma Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Type, 2017–2031

        11.2.1. Pure-PRP

        11.2.2. Leukocyte-rich PRP

        11.2.3. Pure-PRF

    11.3. Market Value Forecast, by Origin, 2017–2031

        11.3.1. Autologous

        11.3.2. Allogeneic

        11.3.3. Homologous

    11.4. Market Value Forecast, by Application, 2017–2031

        11.4.1. Orthopedic Surgery

        11.4.2. Cosmetic Surgery

        11.4.3. General Surgery

        11.4.4. Neurosurgery

        11.4.5. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Type

        11.6.2. By Origin

        11.6.3. By Application

        11.6.4. By Country/Sub-region

12. Asia Pacific Global Platelet Rich Plasma Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Type, 2017–2031

        12.2.1. Pure-PRP

        12.2.2. Leukocyte-rich PRP

        12.2.3. Pure-PRF

    12.3. Market Value Forecast, by Origin, 2017–2031

        12.3.1. Autologous

        12.3.2. Allogeneic

        12.3.3. Homologous

    12.4. Market Value Forecast By Application, 2017–2031

        12.4.1. Orthopedic Surgery

        12.4.2. Cosmetic Surgery

        12.4.3. General Surgery

        12.4.4. Neurosurgery

        12.4.5. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Type

        12.6.2. By Origin

        12.6.3. By Application

        12.6.4. By Country/Sub-region

13. Latin America Global Platelet Rich Plasma Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Type, 2017–2031

        13.2.1. Pure-PRP

        13.2.2. Leukocyte-rich PRP

        13.2.3. Pure-PRF

    13.3. Market Value Forecast, by Origin, 2017–2031

        13.3.1. Autologous

        13.3.2. Allogeneic

        13.3.3. Homologous

    13.4. Market Value Forecast, by Application, 2017–2031

        13.4.1. Orthopedic Surgery

        13.4.2. Cosmetic Surgery

        13.4.3. General Surgery

        13.4.4. Neurosurgery

        13.4.5. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Type

        13.6.2. By Origin

        13.6.3. By Application

        13.6.4. By Country/Sub-region

14. Middle East & Africa Global Platelet Rich Plasma Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Type, 2017–2031

        14.2.1. Pure-PRP

        14.2.2. Leukocyte-rich PRP

        14.2.3. Pure-PRF

    14.3. Market Value Forecast, by Origin, 2017–2031

        14.3.1. Autologous

        14.3.2. Allogeneic

        14.3.3. Homologous

    14.4. Market Value Forecast, by Application, 2017–2031

        14.4.1. Orthopedic Surgery

        14.4.2. Cosmetic Surgery

        14.4.3. General Surgery

        14.4.4. Neurosurgery

        14.4.5. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Type

        14.6.2. By Origin

        14.6.3. By Application

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Company Profiles

        15.2.1. Zimmer Biomet Holdings, Inc.

            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.1.2. Financial Overview

            15.2.1.3. Product Portfolio

            15.2.1.4. Strategic Overview

            15.2.1.5. SWOT Analysis

        15.2.2. AdiStem Ltd.

            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.2.2. Financial Overview

            15.2.2.3. Product Portfolio

            15.2.2.4. Strategic Overview

            15.2.2.5. SWOT Analysis

        15.2.3. ISTO Biologics

            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.3.2. Financial Overview

            15.2.3.3. Product Portfolio

            15.2.3.4. Strategic Overview

            15.2.3.5. SWOT Analysis

        15.2.4. ThermoGenesis Holdings, Inc.

            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.4.2. Financial Overview

            15.2.4.3. Product Portfolio

            15.2.4.4. Strategic Overview

            15.2.4.5. SWOT Analysis

        15.2.5. Stryker Corporation

            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.5.2. Financial Overview

            15.2.5.3. Product Portfolio

            15.2.5.4. Strategic Overview

            15.2.5.5. SWOT Analysis

        15.2.6. Exactech, Inc.

            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.6.2. Financial Overview

            15.2.6.3. Product Portfolio

            15.2.6.4. Strategic Overview

            15.2.6.5. SWOT Analysis

        15.2.7. EmCyte Corporation

            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.7.2. Financial Overview

            15.2.7.3. Product Portfolio

            15.2.7.4. Strategic Overview

            15.2.7.5. SWOT Analysis

        15.2.8. Regen Lab

            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.8.2. Financial Overview

            15.2.8.3. Product Portfolio

            15.2.8.4. Strategic Overview

            15.2.8.5. SWOT Analysis

        15.2.9. Arthrex, Inc.

            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.9.2. Financial Overview

            15.2.9.3. Product Portfolio

            15.2.9.4. Strategic Overview

            15.2.9.5. SWOT Analysis

        15.2.10. TERUMO BCT, INC. (Terumo Corporation)

            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.10.2. Financial Overview

            15.2.10.3. Product Portfolio

            15.2.10.4. Strategic Overview

            15.2.10.5. SWOT Analysis

        15.2.11. DePuy Synthes Companies (Johnson & Johnson)

            15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.11.2. Financial Overview

            15.2.11.3. Product Portfolio

            15.2.11.4. Strategic Overview

            15.2.11.5. SWOT Analysis

        15.2.12. APEX Biologix, LLC

            15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.12.2. Financial Overview

            15.2.12.3. Product Portfolio

            15.2.12.4. Strategic Overview

            15.2.12.5. SWOT Analysis

List of Tables

Table 01: Global Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 02: Global Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Origin, 2017-2031

Table 03: Global Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 04: Global Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 05: North America Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 06: North America Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 07: North America Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Origin, 2017-2031

Table 08: North America Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 09: Europe Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 10: Europe Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 11: Europe Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Origin, 2017-2031

Table 12: Europe Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 13: Asia Pacific Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 14: Asia Pacific Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 15: Asia Pacific Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Origin, 2017-2031

Table 16: Asia Pacific Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Application, 2017-2031

List of Figures

Figure 01: Global Platelet Rich Plasma Market Value (US$ Mn) Forecast, 2017-2031

Figure 02: Global Platelet Rich Plasma Market Value Share, by Type, 2020

Figure 03: Global Platelet Rich Plasma Market Value Share, by Origin, 2020

Figure 04: Global Platelet Rich Plasma Market Value Share, by Application, 2020

Figure 05: Global Platelet Rich Plasma Market Value Share, by Region, 2020

Figure 06: Global Platelet Rich Plasma Market Value (US$ Mn), by Pure-PRF, 2017-2031

Figure 07: Global Platelet Rich Plasma Market Value Share Analysis, by Type, 2020 and 2031

Figure 08: Global Platelet Rich Plasma Market Value (US$ Mn), by Pure-PRP, 2017–2031

Figure 09: Global Platelet Rich Plasma Market Value (US$ Mn), by Pure-PRF, 2017–2031

Figure 10: Global Platelet Rich Plasma Market Attractiveness Analysis, by Type, 2021–2031

Figure 11: Global Platelet Rich Plasma Market Value Share Analysis, by Type, 2020 and 2031

Figure 12: Global Platelet Rich Plasma Market Value (US$ Mn), by Autologous 2017–2031

Figure 13: Global Platelet Rich Plasma Market Value (US$ Mn), by Allogeneic, 2017–2031

Figure 14: Global Platelet Rich Plasma Market Value (US$ Mn), by Pure-PRF, 2017–2031

Figure 15: Global Platelet Rich Plasma Market Attractiveness Analysis, by Origin, 2021–2031

Figure 16: Global Platelet Rich Plasma Market Value Share Analysis, by Type, 2020 and 2031

Figure 17: Global Platelet Rich Plasma Market Value (US$ Mn), by Orthopedic Surgery, 2017–2031

Figure 18: Global Platelet Rich Plasma Market Value (US$ Mn), by Cosmetic Surgery, 2017–2031

Figure 19: Global Platelet Rich Plasma Market Value (US$ Mn), by General Surgery, 2017–2031

Figure 20: Global Platelet Rich Plasma Market Value (US$ Mn), by Neurosurgery, 2017–2031

Figure 21: Global Platelet Rich Plasma Market Value (US$ Mn), by Others, 2017–2031

Figure 23: Global Platelet Rich Plasma Market Value Share Analysis, by Region, 2020 and 2031

Figure 24: Global Platelet Rich Plasma Market Attractiveness Analysis, by Region, 2021–2031

Figure 25: North America Platelet Rich Plasma Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 26: North America Platelet Rich Plasma Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 27: North America Platelet Rich Plasma Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 28: North America Platelet Rich Plasma Market Value Share (%), by Type, 2020 and 2031

Figure 29: North America Platelet Rich Plasma Market Attractiveness, by Type, 2021–2031

Figure 30: North America Platelet Rich Plasma Market Value Share (%), by Origin, 2020 and 2031

Figure 31: North America Platelet Rich Plasma Market Attractiveness, by Origin, 2021–2031

Figure 32: North America Platelet Rich Plasma Market Value Share (%), by Application, 2020 and 2031

Figure 33: North America Platelet Rich Plasma Market Attractiveness Analysis, by Application, 2021–2031

Figure 34: Europe Platelet Rich Plasma Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 35: Europe Platelet Rich Plasma Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 36: Europe Platelet Rich Plasma Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 37: Europe Platelet Rich Plasma Market Value Share (%), by Type, 2020 and 2031

Figure 38: Europe Platelet Rich Plasma Market Attractiveness, by Type, 2021–2031

Figure 39: Europe Platelet Rich Plasma Market Value Share (%), by Origin, 2020 and 2031

Figure 40: Europe Platelet Rich Plasma Market Attractiveness, by Origin, 2021–2031

Figure 41: Europe Platelet Rich Plasma Market Value Share (%), by Application, 2020 and 2031

Figure 42: Europe Platelet Rich Plasma Market Attractiveness Analysis, by Application, 2021–2031

Figure 43: Asia Pacific Platelet Rich Plasma Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 44: Asia Pacific Platelet Rich Plasma Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 45: Asia Pacific Platelet Rich Plasma Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 46: Asia Pacific Platelet Rich Plasma Market Value Share (%), by Type, 2020 and 2031

Figure 47: Asia Pacific Platelet Rich Plasma Market Attractiveness, by Type, 2021–2031

Figure 48: Asia Pacific Platelet Rich Plasma Market Value Share (%), by Origin, 2020 and 2031

Figure 49: Asia Pacific Platelet Rich Plasma Market Attractiveness, by Origin, 2021–2031

Figure 50: Asia Pacific Platelet Rich Plasma Market Value Share (%), by Application, 2020 and 2031

Figure 51: Asia Pacific Platelet Rich Plasma Market Attractiveness Analysis, by Application, 2021–2031

Figure 52: Latin America Platelet Rich Plasma Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 53: Latin America Platelet Rich Plasma Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 54: Latin America Platelet Rich Plasma Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 55: Latin America Platelet Rich Plasma Market Value Share (%), by Type, 2020 and 2031

Figure 56: Latin America Platelet Rich Plasma Market Attractiveness, by Type, 2021–2031

Figure 57: Latin America Platelet Rich Plasma Market Value Share (%), by Origin, 2020 and 2031

Figure 58: Latin America Platelet Rich Plasma Market Attractiveness, by Origin, 2021–2031

Figure 59: Latin America Platelet Rich Plasma Market Value Share (%), by Application, 2020 and 2031

Figure 60: Latin America Platelet Rich Plasma Market Attractiveness Analysis, by Application, 2021–2031

Figure 61: Middle East and Africa Platelet Rich Plasma Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 62: Middle East and Africa Platelet Rich Plasma Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 63: Middle East and Africa Platelet Rich Plasma Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 64: Middle East and Africa Platelet Rich Plasma Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 65: Middle East and Africa Platelet Rich Plasma Market Value Share (%), by Type, 2020 and 2031

Figure 66: Middle East and Africa Platelet Rich Plasma Market Attractiveness, by Type, 2021–2031

Figure 67: Middle East and Africa Platelet Rich Plasma Market Value Share (%), by Origin, 2020 and 2031

Figure 68: Middle East and Africa Platelet Rich Plasma Market Attractiveness, by Origin, 2021–2031

Figure 69: Middle East and Africa Platelet Rich Plasma Market Value Share (%), by Application, 2020 and 2031

Figure 70: Middle East and Africa Platelet Rich Plasma Market Attractiveness Analysis, by Application, 2021–2031

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Platelet-rich Plasma Market